These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19820293

  • 1. Simvastatin protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
    Yao XM, Ye SD, Zai Z, Chen Y, Li XC, Yang GW, Wang YX, Chen K.
    J Endocrinol Invest; 2010 May; 33(5):292-6. PubMed ID: 19820293
    [Abstract] [Full Text] [Related]

  • 2. Renoprotective effect of rosiglitazone through the suppression of renal intercellular adhesion molecule-1 expression in streptozotocin-induced diabetic rats.
    Qian Y, Li S, Ye S, Chen Y, Zhai Z, Chen K, Yang G.
    J Endocrinol Invest; 2008 Dec; 31(12):1069-74. PubMed ID: 19246972
    [Abstract] [Full Text] [Related]

  • 3. Rosiglitazone protects diabetic rats against kidney injury through the suppression of renal matrix metalloproteinase-9 expression.
    Yao XM, Ye SD, Chen Y, Zai ZM, Li XC, Wang YX, Chen K.
    Diabetes Obes Metab; 2009 May; 11(5):519-22. PubMed ID: 19236438
    [Abstract] [Full Text] [Related]

  • 4. Rosiglitazone protects diabetic rats against kidney disease through the suppression of renal moncyte chemoattractant protein-1 expression.
    Zheng M, Ye S, Zhai Z, Chen Y, Li X, Yang G, Fan A, Wang Y.
    J Diabetes Complications; 2009 May; 23(2):124-9. PubMed ID: 18413206
    [Abstract] [Full Text] [Related]

  • 5. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 6. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L, Zheng YF, Dai Y, Dai DZ.
    J Pharm Pharmacol; 2009 Jun 20; 61(6):775-80. PubMed ID: 19505368
    [Abstract] [Full Text] [Related]

  • 7. Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.
    Qin J, Zhang Z, Liu J, Sun L, Hu L, Cooper ME, Cao Z.
    Kidney Int; 2003 Aug 20; 64(2):565-71. PubMed ID: 12846751
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.
    Zhu B, Shen H, Zhou J, Lin F, Hu Y.
    Nephron Exp Nephrol; 2005 Aug 20; 101(1):e1-8. PubMed ID: 15886498
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Simvastatin attenuates pulmonary vascular remodelling by down-regulating matrix metalloproteinase-1 and -9 expression in a carotid artery-jugular vein shunt pulmonary hypertension model in rats.
    Yao J, Xiong M, Tang B, Chen G, Liang M, Ma X, Wang Z, Wu Z.
    Eur J Cardiothorac Surg; 2012 Nov 20; 42(5):e121-7. PubMed ID: 23087098
    [Abstract] [Full Text] [Related]

  • 15. [Effects of losartan on MT3-MMP and TIMP2 mRNA expressions in diabetic rat kidney].
    Wan X, Huang HH, Li JG.
    Di Yi Jun Yi Da Xue Xue Bao; 2004 Dec 20; 24(12):1391-4. PubMed ID: 15604066
    [Abstract] [Full Text] [Related]

  • 16. Lumbrokinase attenuates diabetic nephropathy through regulating extracellular matrix degradation in Streptozotocin-induced diabetic rats.
    Sun H, Ge N, Shao M, Cheng X, Li Y, Li S, Shen J.
    Diabetes Res Clin Pract; 2013 Apr 20; 100(1):85-95. PubMed ID: 23384615
    [Abstract] [Full Text] [Related]

  • 17. Atorvastatin improves pathological changes in the aged kidney by upregulating peroxisome proliferator-activated receptor expression and reducing matrix metalloproteinase-9 and transforming growth factor-β1 levels.
    Zhao J, Cheng Q, Ye P, Yang G, Liu S, Ao Q, Liu Y, Hu Y.
    Exp Gerontol; 2016 Feb 20; 74():37-42. PubMed ID: 26680767
    [Abstract] [Full Text] [Related]

  • 18. Spironolactone exhibits direct renoprotective effects and inhibits renal renin-angiotensin-aldosterone system in diabetic rats.
    Taira M, Toba H, Murakami M, Iga I, Serizawa R, Murata S, Kobara M, Nakata T.
    Eur J Pharmacol; 2008 Jul 28; 589(1-3):264-71. PubMed ID: 18582458
    [Abstract] [Full Text] [Related]

  • 19. [Effects of simvastatin on expression of CTGF and α-SMA in renal tubulointerstitium of rats with diabetic nephropathy].
    Lin FL, Shen HC, Zhu B, Lin KQ.
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2010 Sep 28; 39(5):511-6. PubMed ID: 20936727
    [Abstract] [Full Text] [Related]

  • 20. Effect of catalpol on diabetic nephropathy in rats.
    Dong Z, Chen CX.
    Phytomedicine; 2013 Aug 15; 20(11):1023-9. PubMed ID: 23746755
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.